1 E. Ercan, I. Tengiz, C. Sekuri, E. Aliyev, M. Etemoglu, S. Sari ve M. Akin, “Transbrachial coil occlusion of the large branch of an internal mammary artery coronary graft,” J. Cardiac Surg, 19 (1), 45-46 (2004).
2 Ercan E, Tengiz I, Sekuri C, Sahin F, Aliyev E, Akin M ve Acikel U, “Cardiac thrombi in a patient with protein-C and S deficiencies: a case report,” Thromb. J, 2 (1), 2 (2004).
3 Ercan E, Bozdemir H, Tengiz I, Sekuri C, Aliyev E, Akilli A ve Akin M, “Decreased soluble cell adhesion molecules after tirofiban infusion in patients with unstable angina pectoris,” Thromb. J, 2 (1), 4 (2004).
4 Ercan E, Tengiz I, Altuglu I, Sekuri C, Aliyev E, Ercan H.E ve Akin M, “Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia,” Kardiol. Pol, 60 (5), 454-458 (2004).
5 Ercan E, Tengiz I, Duman C, Sekuri C, Aliyev E, Mutlu B, Ercan H.E ve Akin M, “Decreased plasminogen activator inhibitor-1 levels in coronary artery aneurysmatic patients,” J. Thromb. Thrombolysis, 17 (3), 207-211 (2004).
6 Gulpek D, Bayraktar E, Akbay SP, Capaci K, Kayikcioglu M, Aliyev E, Soydas C. Joint hypermobility syndrome and mitral valve prolapse in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Sep;28(6):969-73.
7 Tengiz I, Ercan E, Aliyev E, Sekuri C, Duman C ve Altuglu I, “Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study,” Curr. Control Trials Cardiovasc. Med, 5 (1), 10 (2004).
8 I. Tengiz, E. Aliyev ve E. Ercan, “An alternative percutaneous interventional approach for post- anastomatic left anterior descending artery stenosis in patients with markedly tortuous LIMA graft,” Int. J. Cardiovasc. Imaging, 21 (5), 491-494 (2005).
9 Tengiz I, Ercan E, Sahin F, Alioglu E, Duman C, Saydam G ve Buyukkececi F, “Presence of factors that activate platelet aggregation in mitral stenotic patients’ plasma,” Curr. Control Trials Cardiovasc. Med, 6 (1), 2 (2005)
10 Tengiz I, Ercan E, Alioglu E ve Turk UO, “Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report,” BMC Cardiovasc Disord, 6(1), 15 (2006).
11 Metin Ergün, Istemihan Tengiz, Ugur Türk, Seckin Senisik, Emin Alioglu, Oguz Yüksel, Ertugrul Ercan ve Cetin Islegen, “The effects of long-term regular exercise on endothelial functions, inflammatory and thrombotic activity in middle-aged, healthy men,” Journal of Sports Science and Medicine, 5, 266-275 (2006).
12 C. Sekuri, F. Cam, A. Sagcan, E. Ercan, I. Tengiz, E. Alioglu ve A. Berdeli, “No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort,” Coron Artery Dis., 18 (5), 333-337 (2007).
13 Alioglu E, Turk UO, Bicak F, Tengiz I, Atila D, Barisik V, Ercan E, Akin M. Vascular endothelial functions, carotid intima-media thickness, and soluble CD40 ligand levels in dipper and nondipper essential hypertensive patients. Clin Res Cardiol. 2008 Jul;97(7):457-62.
14 Cam SF, Sekuri C, Sagcan A, Ercan E, Tengiz I, Alioglu E, Berdeli A. Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease. Scand J Clin Lab Invest. 2008 Jul 24:1-5.
15 Duygu H, Turk U, Ozdogan O, Akyuz S, Kirilmaz B, Alioglu E, Gunduz R, Bozkaya YT, Turkoglu C, Payzin S. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol. Cardiovasc Ther. 2008 Fall;26(3):182-8.
16 Türk U, Alioğlu E, Tengiz I, Ercan E, Mahmudov R, Duygu H, Türkoğlu C. “Statin use is associated with decreased CD-40 ligand expression on T lymphocytes of coronary atheroma plaque in patients with stable coronary artery disease.” Anadolu Kardiyol Derg. 2008 Apr;8(2):99-103.
17 Tamer GS, Tengiz I, Ercan E, Duman C, Alioglu E, Turk UO. Helicobacter pylori Seropositivity in Patients with Acute Coronary Syndromes. Dig Dis Sci. 2008 Sep 4
18 Alioğlu E, Ercan E, Tengiz I, Yildiz A, Onsel Türk U, Saygi S, Cam FS, Berdeli A.” G protein beta3 subunit gene polymorphism in Turkish hypertensives.”Anadolu Kardiyol Derg. 2008 Oct;8(5):331-5.
19 Alioglu E, Ercan E, Tamer GS, Duman C, Turk UO, Tengiz I, Tuzun N, Saygi S, “ Decreased circulatory erythropoietin in hyperacute phase of myocardial ischemia”. Int J Cardiol. 2009 Jan 24
20 Alioglu E, Turk U, Cam S, Abbasaliyev A,Tengiz I, Ercan E. Polymorphism of the methylenetetrahydrofolate reductase, vascular endothelial growth factor, endothelial nitric oxide syntase, monocyte chemoatracttant protein-1 and apolipoprotein E genes are not associated with carotid intima media thickness. Can J Cardiol. 2009, 25(1),e1-e5
21 Alioglu E, Tuzun N, Sahin F, Kosova B, Saygi S, Tengiz I, Turk U, Ozsan N, Ercan E. Non ST-segment elevation myocardial infarction in patient with essential thrombocythemia. Thromb J. 2009 Feb 20; 7:1.
22 Alioglu E, Turk UO, Engin C, Tengiz I, Tuzun N, Posacioglu H. Left main coronary artery aneurysm in young patient with acute myocardial infarction. J Cardiovasc Med (Hagerstown). 2009 Mar 20
23 Türk UO, Alioğlu E, Ercan E, Duygu H. “Abnormal elongated chordae tendinea protruding to the left ventricular outflow tract”. Anadolu Kardiyol Derg. 2009 10; 9(2):E-5.
24 Turk BG, Turk UO, Alioglu E, Akalin T, Dereli T. Stewart-Bluefarb syndrome: a case report with angiographic findings. J Dermatol. 2009 Jul;36(7):415-8.
25 Turk U, Alioglu E, Kirilmaz B, Duygu H, Tuzun N, Tengiz I, Zoghi M, Ercan E. Prediction of Head-Up Tilt Test Result: Is it Possible? Pacing Clin Electrophysiol. 2009 Nov 2 [Epub ahead of print]
26 Kirilmaz B, Asgun F, Alioglu E, Ercan E, Tengiz I, Turk U, Saygi S, Ozerkan F. High inflammatory activity related to the number of metabolic syndrome components. J Clin Hypertens (Greenwich). 2010 Feb 1;12(2):136-44. 12
27 Alioğlu E, Ercan E, Tengiz I, Türk UO, Ergün M, Akgöz S, Işlegen C, Berdeli A. The influence of α-adducin gene polymorphism on response of blood pressure to exercise in patients with hypertension. Anadolu Kardiyol Derg. 2010 Oct;10(5):400-4
28 Serkan S, Alioğlu E, Türk U, Tüzün N, Kırılmaz B, Tengiz I, Ercan E. Thrombotic occlusion of a left main coronary artery in a patient with prosthetic mitral valve. Anadolu Kardiyol Derg. 2010 Dec;10(6):553-4. 11
29 Saygi S, Alioglu E, Karabulut MehmetN, Onsel Ugur Turk, Kirilmaz Bahadir, Tuzun Nurullah, Sahin Fahri, Kosova Buket, Tengiz Istemihan. A Floatıng Thrombus In Sınus Of Valsalva Complicated With Cardiogenic Shock In A Patient With Plasmınogen Activator Inhibitor 1 4G/5G Polymorphism. Echocardiography 2011 May 4 doi: 10.1111/j.1540-8175.2011.01432.x. 9
30 Saygi S, Turk UO, Alioglu E, Kirilmaz B, Tengiz I, Tuzun N, Ercan E. Left Atrial Appendage Functions in Mitral Stenosis: Is it Determined by Cardiac Rhythm? J Heart Valve Dis 2011 Jul;20(4):417-24. 17
31 Saygi S, Alioglu E, Karabulut MN, Turk UO, Kirilmaz B, Tuzun N, Sahin F, Kosova B, Tengiz I. A floating thrombus in sinus of valsalva complicated with cardiogenic shock in a patient with plasminogen activator inhibitor 1 4G/5G polymorphism. Echocardiography. 2011 Sep;28(8): E164-7.
32 Saygi S, Turk UO, Alioglu E, Kirilmaz B, Tengiz I, Tuzun N, Ercan E. Left atrial appendage function in mitral stenosis: is it determined by cardiac rhythm? J Heart Valve Dis. 2011 Jul;20(4):417-
24 33 Alioglu E, Saygi S, Turk U, Kirilmaz B, Tuzun N, Duman C, Tengiz I, Yildiz S, Ercan E. N- acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin C. Cardiovasc Ther. 2013 Jun;31(3):168-73.
34 Saygı S, Kırılmaz B, Tengiz İ, Türk UÖ, Yıldız H, Tuzun N, Alioğlu E, Tamer GS, Ercan E. Long pentraxin-3 measured at late phase associated with GRACE risk scores in patients with non-ST elevation acute coronary syndrome and coronary stenting. Turk Kardiyol Dern Ars. 2012 Apr;40(3):205-12.
35 Kirilmaz B, Saygi S, Gungor H, Onsel Turk U, Alioğlu E, Akyuz S, Asgun F, Tengiz I, Ercan E. Digoxin intoxication: An old enemy in modern era. J Geriatr Cardiol. 2012 Sep;9(3):237-42.
36 Ertaş FS, Tokgözoğlu L; EPICOR Study Group. Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study. Anatol J Cardiol. 2016 Dec;16(12):900-915.
37 Türk UÖ, Alioğlu E, Tunçer E, Özpelit ME, Pekel N, Tengiz İ, Çetin N, Dalgıç O, Topaloğlu C, Bilgin N, Altın C, Özdemirkıran T, Tülüce K, Türkoğlu Eİ, Özpelit E. Design and rationale of dabigatran’s stroke prevention in real life in Turkey (D-SPIRIT). Turk Kardiyol Dern Ars. 2016 Apr;44(3):221-7.
38 Turk UO, Tuncer E, Alioglu E, Yuksel K, Pekel N, Ozpelit E, Vuran O, Tengiz I. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry. Cardiol J. 2015;22(5):567-75.
39 Turk U, Turk BG, Yılmaz SG, Tuncer E, Alioğlu E, Dereli T. Amiodarone-induced multiorgan toxicity with ocular findings on confocal microscopy. Middle East Afr J Ophthalmol. 2015 Apr- Jun;22(2):258-60.
40 Ercan E, Tengiz I, Turk U, Ozyurtlu F, Alioglu E. A new device for paravalvular leak closure. J Geriatr Cardiol. 2015 Mar;12(2):187-8.
41 Bueno H, Sinnaeve P, Annemans L, Danchin N, Licour M, Medina J, Pocock S, Sánchez-Covisa J, Storey RF, Jukema JW, Zeymer U, Van de Werf F; EPICOR Investigators. Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns. Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):3-12.
42 Turk UO, Tuncer E, Alioglu E, Tengiz I, Ercan E. Inadvertent implantation of pacemaker lead in the left ventricle: kill two birds with one stone. Int Cardiovasc Res J. 2014 Apr;8(2):71-3.
43 Tuncer E, Turk U, Alioglu E. Cardiac hydatid cyst: an unusual cause of chest pain. Int Cardiovasc Res J. 2013 Dec;7(4):150-1.
44 Turk U, Tengiz I, Ozpelit E, Celebiler A, Pekel N, Ozyurtlu F, Alioglu E, Ercan E. The relationship between platelet indices and clinical features of coronary artery disease. Kardiol Pol. 2013;71(11):1129-34.
45 Tuncer E, Onsel Turk U, Alioglu E. Giant saccular aneurysm of the left main coronary artery. J Geriatr Cardiol. 2013 Mar;10(1):110-2.
47 Tengiz İ, Türk UÖ, Alioğlu E, Kırılmaz B, Tamer GS, Tüzün N, Ercan E. The relationship between adiponectin, NT-pro-BNP and left ventricular ejection fraction in non-cachectic patients with systolic heart failure: an observational study. Anadolu Kardiyol Derg. 2013 May;13(3):221-6.
48 Tuncer E, Yavuz V, Turk UO, Alioglu E. Why fear can be fatal? J Cardiovasc Med (Hagerstown). 2017 Sep;18(9):700-701.
49 Kozan Ö, Tengiz I, Özcan EE, Özpelit ME, Taştan A, Türk UÖ, Alioğlu E, ErcanE. [The evaluation of hypertensive patients who are supposedly under control according to office blood pressure measurements with ambulatuar blood pressure monitoring: an observational prospective study in three big cities (AKB3IL study)]. Turk Kardiyol Dern Ars. 2012 Sep;40(6):481-90.
50 Tengiz İ, Türk UÖ, Alioğlu E, Kırılmaz B, Tamer GS, Tüzün N, Ercan E. The relationship between adiponectin, NT-pro-BNP and left ventricular ejection fraction in non-cachectic patients with systolic heart failure: an observational study. Anadolu Kardiyol Derg. 2013 May;13(3):221-6.
51 Tuncer E, Onsel Turk U, Alioglu E. Giant saccular aneurysm of the left main coronary artery. J Geriatr Cardiol. 2013 Mar;10(1):110-2.
52 Turk U, Tengiz I, Ozpelit E, Celebiler A, Pekel N, Ozyurtlu F, Alioglu E, Ercan E. The relationship between platelet indices and clinical features of coronary artery disease. Kardiol Pol. 2013;71(11):1129-34.
53 Tuncer E, Turk U, Alioglu E. Cardiac hydatid cyst: an unusual cause of chest pain. Int Cardiovasc Res J. 2013 Dec;7(4):150-1.
54 Turk UO, Tuncer E, Alioglu E, Tengiz I, Ercan E. Inadvertent implantation of pacemaker lead in the left ventricle: kill two birds with one stone. Int Cardiovasc Res J. 2014 Apr;8(2):71-3.
55 Bueno H, Sinnaeve P, Annemans L, Danchin N, Licour M, Medina J, Pocock S, Sánchez-Covisa J, Storey RF, Jukema JW, Zeymer U, Van de Werf F; EPICOR Investigators. Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns. Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):3-12.
56 Ercan E, Tengiz I, Turk U, Ozyurtlu F, Alioglu E. A new device for paravalvular leak closure. JGeriatr Cardiol. 2015 Mar;12(2):187-8.
57 Turk U, Turk BG, Yılmaz SG, Tuncer E, Alioğlu E, Dereli T. Amiodarone-induced multiorgan toxicity with ocular findings on confocal microscopy. Middle East Afr J Ophthalmol. 2015 Apr-Jun;22(2):258-60.
58 Turk UO, Tuncer E, Alioglu E, Yuksel K, Pekel N, Ozpelit E, Vuran O, Tengiz I. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational,prospective WATER Registry. Cardiol J. 2015;22(5):567-75
59 Türk UÖ, Alioğlu E, Tunçer E, Özpelit ME, Pekel N, Tengiz İ, Çetin N, Dalgıç O, Topaloğlu C,Bilgin N, Altın C, Özdemirkıran T, Tülüce K, Türkoğlu Eİ, Özpelit E. Design and rationale of dabigatran’s stroke prevention in real life in Turkey (D-SPIRIT). Turk Kardiyol Dern Ars. 2016 Apr;44(3):221-7.
60 Ertaş FS, Tokgözoğlu L; EPICOR Study Group. Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study. Anatol J Cardiol. 2016 Dec;16(12):900-915.
61 Türk UÖ, Alioğlu E. Remote monitoring with cardiac implantable electronicdevice to follow up pharmacodynamic effects of sacubitril/ valsartan treatment: A case report. Turk Kardiyol Dern Ars.2019 Jan;47(1)